Journal Club 2024-2025 Year to Date Articles
September 5, 2024: Taye, Kondle

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (TT)

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer A Nonrandomized Controlled Trial (SK)

October 29, 2024: Hulgan, Malinosky

Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure Results From SOLOIST-WHF (DH)

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (HM)

November 12, 2024: Plumber, Koneru

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes (AP)

Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis (SK)

January 2, 2025: Shah, Azhar

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (ZS)

Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam (AA)

January 14, 2025: Momin, Weinstein

Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk (AM)

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma (KW)

January 21, 2025: Gokani, Moore

Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura (VG)

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis (CM)

January 31, 2025: Nguyen, Bartley

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (JN)

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BB)

March 18, 2025: Lujan, Abdelwahab

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (SL)

Inebilizumab for Treatment of IgG4-Related Disease (RA)
March 19, 2025: Saji, Denys

A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome (AS)

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (AD)

March 31, 2025: Veeramachaneni, Rizvi

90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial (TV)

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis (TR)

April 23, 2025: Nagineni, Santiago

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer (LN)

Ponsegromab for the Treatment of Cancer Cachexia (KS)

June 12, 2025: Thiruma, Hoang